ASH 2015

Area: Hematology

Location: Orlando, United States

Date: December 5 to December 8

Description:

American Society of Hematology.


Search in Scientific Content:
Date
Filters:
Update of
9:15

Update of Results from the Northstar Study (HGB-204): A Phase 1/2 Study of Gene Therapy for Beta-Thalassemia Major

Presenter: Mark C. Walters
Hematology
Safety and
8:36

Safety and Clinical Benefit of Lentiviral Hematopoietic Stem Cell Gene Therapy for Wiscott-Aldrich Syndrome

Presenter: Francesca Ferrua
Hematology

Lentivector Gene Therapy for X-linked Severe Combined Immune Deficiency in Older Children/Young Adults

Presenter: Suk See De Ravin
Hematology
Allogeneic
7:41

Allogeneic T-Cells Expressing an Anti-CD19 Chimeric AR Cause Remissions of B-Cell Malignancies after Allogeneic Hematopoietic SCT

Presenter: James N. Kochenderfer
Hematology
Remissions
7:16

Remissions of Multiple Myeloma during a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor

Presenter: James N. Kochenderfer
Hematology

Genetic Risk Factors for the Development of Osteonecrosis in Children Under Age 10 Treated for ALL

Presenter: Seth E. Karol
Hematology

Homozygosity for the 2R Tandem Repeat Polymorphism Is Associated with Increased Risk for Bony Morbidity

Presenter: Peter Cole
Hematology
Genetic an
6:26

Genetic and Response-Based Risk Classification Identifies a Subgroup of NCI High Risk HR B-ALL with Outstanding Outcomes

Presenter: Elizabeth Raetz
Hematology

Genes Influencing the Development and Severity of Chronic ITP Identified through Whole Exome Sequencing

Presenter: Jenny M. Despotovic
Hematology

Mercaptopurine (6MP) Intake during Maintenance for Childhood ALL - a Comparison of Self-Report and Electronic Monitoring

Presenter: Wendy Landier
Hematology

Tissue Oxygenation By Transfusion in Severe Anemia with Lactic Acidosis (TOTAL)

Presenter: Christina Cserti-Gazdewich
Hematology

Enoxaparin Dose Reduction for Thrombocytopenia in Patients with Cancer: A Quality Assessment Study

Presenter: Gerald A. Soff
Hematology
Switching
4:42

Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis

Presenter: Chatree Chai-Adisaksopha
Hematology

Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

Presenter: Danielle Townsley
Hematology

Hematopoietic SCT from HLA Identical Sibling Forsickle Cell Disease an International Survey

Presenter: Barbara Cappelli
Hematology

Potent Anti-Sickling Hgb Modifier Reduces Hemolysis, Improves Anemia and Nearly Eliminates Sickle Cells

Presenter: Claire Hemmaway
Hematology
Novelties
4:39

Novelties in the treatment of AML at ASH 2015

Presenter: Mark Levis
Hematology
Developmen
8:48

Developments in the treatment of lymphoma

Presenter: Owen O'Connor
Hematology
Update in
6:06

Update in treatment of acute myeloid and acute lymphoblastic leukaemia

Presenter: Farhad Ravandi
Hematology
Non-Hodgki
6:00

Non-Hodgkin lymphoma treatment update at ASH 2015

Presenter: Andrew M. Evens
Hematology
ASH Annual
8:44

ASH Annual Meeting Highlights

Presenter: David A. Williams
Hematology
What is go
5:34

What is going on in ALL? ASH 2015 update

Presenter: Elias Jabbour
Hematology
Novel comb
8:31

Novel combinations approved in multiple myeloma

Presenter: Shaji Kumar
Hematology

ASH 2018

2018-12-01 - 2018-12-04
San Diego, United States

EHA 2018

2018-06-14 - 2018-06-17
Stockholm, Sweden

ASH 2017

2017-12-09 - 2017-12-12
Atlanta, United States

EHA 2017

2017-06-22 - 2017-06-25
Madrid, Spain

ICML 2017

2017-06-14 - 2017-06-17
Lugano, Switzerland

ASH 2016

2016-12-03 - 2016-12-06
San Diego, United States

EHA 2015

2015-06-11 - 2015-06-14
Vienna, Australia